<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01179477</url>
  </required_header>
  <id_info>
    <org_study_id>CRD561</org_study_id>
    <nct_id>NCT01179477</nct_id>
  </id_info>
  <brief_title>QuickFlex Micro Left Ventricular Lead Post Approval Study</brief_title>
  <official_title>QuickFlex® μ Model 1258T Left Heart Pacing Lead Post Approval Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abbott Medical Devices</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abbott Medical Devices</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this multicenter post-approval study is to evaluate the acute and chronic
      performance of the QuickFlex® μ 1258T left ventricular (LV) lead.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary endpoints of the study are:

        -  Freedom from LV lead-related complications at 5 years

        -  LV bipolar capture threshold of St. Jude Medical's QuickFlex®µ 1258T LV Lead measured at
           0.5 ms at 5 years
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 2010</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percent of Participants Alive and Without a Left Ventricular Lead-related Complication</measure>
    <time_frame>5 years</time_frame>
    <description>Percent of Participants Alive and Without a Left Ventricular Lead-related Complication at 5 years of follow-up. Per FDA, data from IDE subjects who did not consent to rollover into the post approval study at sites participating in the post approval study, were included in this analysis (see clinical investigational protocol).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Left Ventricular Bipolar Pacing Capture Threshold</measure>
    <time_frame>5 years</time_frame>
    <description>Mean left ventricular bipolar pacing capture threshold measured at 0.5 ms pulse width at 5 years of follow-up</description>
  </primary_outcome>
  <enrollment type="Actual">1930</enrollment>
  <condition>Heart Failure</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Implantation of a QuickFlex® μ Model 1258T LV Lead</intervention_name>
    <description>Implantation of a QuickFlex® μ Model 1258T LV Pacing Lead</description>
    <other_name>LV pacing lead</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with an approved indication for implantation of a CRT-D system
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have an approved indication per American College of Cardiology/American Heart
             Association/Heart Rhythm Society guidelines for implantation of a CRT-D system or
             participated in the QuickFlex® μ1258T (Investigational Device Exemption (IDE) study

          -  Have the ability to provide informed consent for study participation and be willing
             and able to comply with the prescribed follow-up tests and schedule of evaluations

        Exclusion Criteria:

          -  Have a hypersensitivity to a single 1.0mg dose of dexamethasone sodium phosphate or
             short term contact with heparin

          -  Have a life expectancy of less than 5 years due to any condition

          -  Be less than 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Clay Cohorn</last_name>
    <role>Study Director</role>
    <affiliation>Abbott Medical Devices</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cardiovascular Associates P.C.</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital - Univ. of Alabama at Birmingham (UAB)</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Center Research, LLC.</name>
      <address>
        <city>Huntsville</city>
        <state>Alabama</state>
        <zip>35801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Alaska Heart Institute</name>
      <address>
        <city>Anchorage</city>
        <state>Alaska</state>
        <zip>99508</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Arrhythmia Research Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85013</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arizona Arrhythmia Consultants</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85252</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Cardiology</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Vincent Heart Clinic Arkansas</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Heart Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwest Cardiology</name>
      <address>
        <city>Springdale</city>
        <state>Arkansas</state>
        <zip>72764</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Glendale Memorial Hospital and Medical Center</name>
      <address>
        <city>Glendale</city>
        <state>California</state>
        <zip>91206</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kaiser Permanente Los Angeles Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cardiology Associates</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95819</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California at San Diego (UCSD) Medical Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92118</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Claudio Bonometti MD, Inc</name>
      <address>
        <city>Santa Barbara</city>
        <state>California</state>
        <zip>93105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Los Angeles Biomedical Research Institute at Harbor-UCLA</name>
      <address>
        <city>Torrance</city>
        <state>California</state>
        <zip>90502</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Christiana Hospital</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Shands Jacksonville</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32209</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Naushad Shaik, MD</name>
      <address>
        <city>Kissimmee</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Munroe Regional Medical Center</name>
      <address>
        <city>Ocala</city>
        <state>Florida</state>
        <zip>34471</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Usman R. Siddiqui, MD</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32803</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orlando Heart Center</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brevard Cardiovascular Research Associates, Inc.</name>
      <address>
        <city>Rockledge</city>
        <state>Florida</state>
        <zip>32955</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of South Florida, Cardiovascular Services</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33606</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Athens Regional Medical Center</name>
      <address>
        <city>Athens</city>
        <state>Georgia</state>
        <zip>30306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Joseph's Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Redmond Regional Medical Center</name>
      <address>
        <city>Rome</city>
        <state>Georgia</state>
        <zip>30165</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prairie Education and Research Cooperative</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Parkview Research Center</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46805</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Heart Group</name>
      <address>
        <city>Newburgh</city>
        <state>Indiana</state>
        <zip>47630</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Iowa Heart Center</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mid-America Cardiology Associates, PC</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>King's Daughters Medical Center</name>
      <address>
        <city>Ashland</city>
        <state>Kentucky</state>
        <zip>41101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Central Baptist Hospital</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Norton Bluegrass Heart Specialists</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40217</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Peninsula Cardiology Associates, P.A.</name>
      <address>
        <city>Salisbury</city>
        <state>Maryland</state>
        <zip>21804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Trinity Health-Michigan d/b/a Michigan Heart</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48197</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Thoracic Cardio Healthcare Found. (aka Sparrow Research)</name>
      <address>
        <city>Lansing</city>
        <state>Michigan</state>
        <zip>48912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MidMichigan Physicians Group</name>
      <address>
        <city>Midland</city>
        <state>Michigan</state>
        <zip>48640</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Jackson Heart Clinic</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Associates of North Mississippi</name>
      <address>
        <city>Tupelo</city>
        <state>Mississippi</state>
        <zip>38801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Missouri Baptist Medical Center</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Heart Consultants P.C.</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AtlantiCare Regional Medical Center</name>
      <address>
        <city>Pomona</city>
        <state>New Jersey</state>
        <zip>08240</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lourdes Cardiology Services</name>
      <address>
        <city>Voorhees</city>
        <state>New Jersey</state>
        <zip>08043</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New Jersey Cardiology Associates</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lenox Hill Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10028</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LeBauer HeartCare</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Medical Center Clinical Sciences</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Primed Cardiology/Kettering Medical Center Network</name>
      <address>
        <city>Kettering</city>
        <state>Ohio</state>
        <zip>45429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Cardiovascular Medical Center</name>
      <address>
        <city>Steubenville</city>
        <state>Ohio</state>
        <zip>43953</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Toledo Hospital</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43615</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Toledo Clinic</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43623</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Elizabeth Health Center</name>
      <address>
        <city>Youngstown</city>
        <state>Ohio</state>
        <zip>44505</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Providence Heart and Vascular Institute</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97220</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tri-State Medical Group Cardiology</name>
      <address>
        <city>Beaver</city>
        <state>Pennsylvania</state>
        <zip>15009</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Capital Cardiovascular Associates</name>
      <address>
        <city>Camp Hill</city>
        <state>Pennsylvania</state>
        <zip>17011</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Donald Guthrie Foundation for Education and Research</name>
      <address>
        <city>Sayre</city>
        <state>Pennsylvania</state>
        <zip>18840</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>WellSpan Health</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17405</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiology Consultants</name>
      <address>
        <city>Johnson City</city>
        <state>Tennessee</state>
        <zip>37601</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist University Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Stern Cardiovascular Foundation</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38120</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Cardiac Arrhythmia</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HeartPlace</name>
      <address>
        <city>Bedford</city>
        <state>Texas</state>
        <zip>76021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Heart Care</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>South Texas Cardiovascular Consultants</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brooke Army Medical Center</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates of East Texas</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McKay-Dee Heart Services</name>
      <address>
        <city>Ogden</city>
        <state>Utah</state>
        <zip>84403</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Hospital</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Associates Ltd</name>
      <address>
        <city>Chesapeake</city>
        <state>Virginia</state>
        <zip>23320</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charleston Area Medical Center</name>
      <address>
        <city>Charleston</city>
        <state>West Virginia</state>
        <zip>25304</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's Hospital</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53715</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiac Rhythm Specialists, S.C.</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53211</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>August 9, 2010</study_first_submitted>
  <study_first_submitted_qc>August 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2010</study_first_posted>
  <results_first_submitted>November 6, 2018</results_first_submitted>
  <results_first_submitted_qc>July 1, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">August 12, 2019</results_first_posted>
  <last_update_submitted>July 1, 2019</last_update_submitted>
  <last_update_submitted_qc>July 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Left heart pacing lead</keyword>
  <keyword>Cardiac resynchronization therapy (CRT)</keyword>
  <keyword>Heart failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Menthol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>June 10, 2010</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/77/NCT01179477/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Per the clinical investigation protocol, IDE subjects (n=54) who did not consent to roll over into the post approval study (PAS) at sites participating in the post approval study, were included in primary endpoint analyses. Since these subjects are not enrolled into the PAS, they are not reflected in the participant flow.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Subjects Implanted With a New QuickFlex μ Lead</title>
          <description>Subjects implanted with a new QuickFlex μ lead and subjects previously enrolled in the QuickFlex μ IDE study were enrolled into the post-approval study. All successfully enrolled subjects were followed every six months for a period of five years.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="1930"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="843"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1087"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="542"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Unsuccessful implant</title>
              <participants_list>
                <participants group_id="P1" count="80"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-death withdrawal</title>
              <participants_list>
                <participants group_id="P1" count="438"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not complete final visit</title>
              <participants_list>
                <participants group_id="P1" count="27"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Subjects Implanted With a New QuickFlex μ Lead</title>
          <description>Subjects implanted with a new QuickFlex μ lead and subjects previously enrolled in the QuickFlex μ IDE study were enrolled into the post-approval study. All successfully enrolled subjects were followed every six months for a period of five years.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="1930"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68.7" spread="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="529"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1401"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic or Latino</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian/Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1646"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1930"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Left Ventricular Ejection Fraction</title>
          <description>LVEF is percent of blood ejected from left ventricle</description>
          <units>Percent of blood ejected</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25.1" spread="7.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Intrinsic QRS duration</title>
          <units>ms</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="152.0" spread="25.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>New York Heart Association (NYHA) Classification at Baseline</title>
          <description>NYHA Functional Classification has 4 categories:
Class I (least severe) - no limitation of physical activity Class II - slight limitation of physical activity Class III - marked limitation of physical activity Class IV (most severe) - unable to carry on any phyiscal activity without discomfort</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Class I</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class II</title>
                  <measurement_list>
                    <measurement group_id="B1" value="175"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class III</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1672"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Class IV</title>
                  <measurement_list>
                    <measurement group_id="B1" value="61"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cardiomyopathy</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Ischemic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1131"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Non-ischemic</title>
                  <measurement_list>
                    <measurement group_id="B1" value="799"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Percent of Participants Alive and Without a Left Ventricular Lead-related Complication</title>
        <description>Percent of Participants Alive and Without a Left Ventricular Lead-related Complication at 5 years of follow-up. Per FDA, data from IDE subjects who did not consent to rollover into the post approval study at sites participating in the post approval study, were included in this analysis (see clinical investigational protocol).</description>
        <time_frame>5 years</time_frame>
        <population>The analysis population for Primary Endpoint #1 includes newly enrolled and IDE rollover subjects with an attempted implant of the QuickFlex μ LV lead (n=1,930) and subjects from the IDE sites that agreed to participate in the post-approval study, but did not consent to rollover into the post-approval study (n=54), for a total of 1,984 subjects.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With a New QuickFlex μ Lead</title>
            <description>Subjects implanted with a new QuickFlex μ lead and subjects previously enrolled in the QuickFlex μ Investigational Device Exemption (IDE) study were enrolled into the PAS study. All successfully enrolled subjects were followed every six months for a period of five years.</description>
          </group>
        </group_list>
        <measure>
          <title>Percent of Participants Alive and Without a Left Ventricular Lead-related Complication</title>
          <description>Percent of Participants Alive and Without a Left Ventricular Lead-related Complication at 5 years of follow-up. Per FDA, data from IDE subjects who did not consent to rollover into the post approval study at sites participating in the post approval study, were included in this analysis (see clinical investigational protocol).</description>
          <population>The analysis population for Primary Endpoint #1 includes newly enrolled and IDE rollover subjects with an attempted implant of the QuickFlex μ LV lead (n=1,930) and subjects from the IDE sites that agreed to participate in the post-approval study, but did not consent to rollover into the post-approval study (n=54), for a total of 1,984 subjects.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1984"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1902"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Left Ventricular Bipolar Pacing Capture Threshold</title>
        <description>Mean left ventricular bipolar pacing capture threshold measured at 0.5 ms pulse width at 5 years of follow-up</description>
        <time_frame>5 years</time_frame>
        <population>Subjects included in this analysis are only those who have left ventricular bipolar pacing capture threshold values reported a the 5-year visit. Of the 843 who completed the 5 year visit, only 774 had analzable data.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Implanted With a New QuickFlex μ Lead</title>
            <description>Subjects implanted with a new QuickFlex μ lead and subjects previously enrolled in the QuickFlex μ Investigational Device Exemption (IDE) study were enrolled into the PAS study. All successfully enrolled subjects were followed every six months for a period of five years.</description>
          </group>
        </group_list>
        <measure>
          <title>Left Ventricular Bipolar Pacing Capture Threshold</title>
          <description>Mean left ventricular bipolar pacing capture threshold measured at 0.5 ms pulse width at 5 years of follow-up</description>
          <population>Subjects included in this analysis are only those who have left ventricular bipolar pacing capture threshold values reported a the 5-year visit. Of the 843 who completed the 5 year visit, only 774 had analzable data.</population>
          <units>Volts</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="774"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.04" spread="1.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Complications and observations post implant through 5 years</time_frame>
      <desc>Complications are considered serious adverse events. A complication is an event caused by or associated with the study device, system component(s) and/or procedure that requires invasive intervention (e.g. post-implant lead dislodgement requiring repositioning).
An observation is an event caused by or associated with the study device, system component(s) and/or procedure that does not require invasive intervention (e.g. over-sensing or loss of pacing capture requiring reprogramming)</desc>
      <group_list>
        <group group_id="E1">
          <title>Subjects Implanted With a New QuickFlex μ Lead</title>
          <description>Subjects implanted with a new QuickFlex μ lead and subjects previously enrolled in the QuickFlex μ Investigational Device Exemption (IDE) study were enrolled into the PAS study. All successfully enrolled subjects were followed every six months for a period of five years.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="542" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="258" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <description>Procedure Related</description>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Erosion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Lead Dislodgement or Migration</sub_title>
                <counts group_id="E1" events="63" subjects_affected="62" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Diaphragmatic/Phrenic Nerve Stimulation</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Induced Atrial or Ventricular Arrhythmias</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Pain/Discomfort At Incision Site</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Pericardial Effusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Cardiac/Coronary Sinus Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Diaphragmatic/Phrenic Nerve Stimulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Dislodgement or Migration</sub_title>
                <counts group_id="E1" events="32" subjects_affected="31" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Cardiac/Coronary Sinus Perforation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Cardiac Tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Pectoral Stimulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Hematoma/Seroma</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Pneumothorax/Hemothorax</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Pericardial Effusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Cardiac/Coronary Sinus Perforation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Cardiac Arrest</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Cardiac Tamponade</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Deep Vein Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Device Migration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Guidewire Stuck In LV Lead</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Lead Dislodgement or Migration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Pleural Effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedural Skin Injury At PG Pocket</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Loss of Capture</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Elevated Pacing Thresholds</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Abnormal LV Lead Pacing Impedance &lt;= 200 OHMS or &gt;= 2000 OHMS</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Lead Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Lead Insulation Damage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Premature Battery Depletion</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Suspected Generator Malfunction</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>LV Lead Loss of Capture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Dislodgement or Migration</sub_title>
                <counts group_id="E1" events="22" subjects_affected="20" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Abnormal Lead Impedance</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Insulation Damage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Loss of Capture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Atrial Lead Noise</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Elevated Pacing Thresholds</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Oversensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Undersensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Elevated Pacing Thresholds</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Fracture</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Insulation Damage</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Abnormal Lead Impedance</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Loss of Capture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Inappropriate Shock</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Oversensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Unable to Defibrillate</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Undersensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Twiddler Syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.1</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="512" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>System/Pulse Generator Related Therapy For Non-Ventricular Rhythm</sub_title>
                <description>(System / PG / Other Leads/ Procedure)</description>
                <counts group_id="E1" events="27" subjects_affected="23" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>System/Pulse Generator Related Idioventricular Rhythm Preventing Biventricular Pacing</sub_title>
                <description>System / PG / Other Leads/ Procedure</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Related Therapy For Non-Ventricular Rhythm</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Other Therapy For Non-Ventricular Rhythm</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Other Pulmonary Edema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Procedure Related Infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Other Infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>LV Diaphragmatic/Phrenic Nerve Stimulation</sub_title>
                <description>LV Lead Related Observations</description>
                <counts group_id="E1" events="164" subjects_affected="145" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>LV Induced Atrial or Ventricular Arrhythmias</sub_title>
                <description>LV Lead Related Observations</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>LV Lead Dislodgement or Migration</sub_title>
                <description>LV Lead Related Observations</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>LV Cardiac/Coronary Sinus Dissection</sub_title>
                <description>LV Lead Related Observations</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>LV Coronary Sinus or Cardiac Vein Thrombosis</sub_title>
                <description>LV Lead Related Observations</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Lead Dislodgement or Migration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Myopotential Sensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Related Bilateral Pleural Effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Related Myopotential Sensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Related Pectoral Stimulation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Hematoma/Seroma</sub_title>
                <counts group_id="E1" events="33" subjects_affected="33" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Cardiac/Coronary Sinus Dissection</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Atrial Arrhythmia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Pericardial Effusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Bleeding And/or Hemoptysis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Cardiac Vein Thrombus</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Part of The Delivery Tool Was Left In The Coronary Sinus/ Ventricle</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Pneumothorax/Hemothorax</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Pulmonary Edema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Renal Failure or Injury</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Acute Left Arm Thrombophlebitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Cardiac/Coronary Sinus Perforation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Decompensated Heart Failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Device Incision Erythema</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Excessive Bleeding</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Frozen Shoulder</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related High DFT's</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Hypotension Requiring Medical Intervention During CRT-D Implant</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Myocardial Infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Procedure Related Pericarditis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Other Pericardial Effusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Other Induced Atrial or Ventricular Arrhythmias</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>LV Lead Elevated Pacing Thresholds</sub_title>
                <description>LV Lead Related Observations</description>
                <counts group_id="E1" events="221" subjects_affected="214" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>LV Loss of Capture</sub_title>
                <description>Lead Related Observations</description>
                <counts group_id="E1" events="20" subjects_affected="19" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>Abnormal LV Lead Pacing Impedance &lt;= 200 Ω or &gt;= 2000 Ω</sub_title>
                <description>LV Lead Related Observations</description>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>LV Lead Insulation Damage</sub_title>
                <description>LV Lead Related Observations</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>System/Pulse Generator Related Failed ICD Shock</sub_title>
                <description>System / PG / Other Leads/ Procedure</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>System/Pulse Generator Related Pacemaker Mediated Tachycardia</sub_title>
                <description>System / PG / Other Leads/ Procedure</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Oversensing</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Abnormal Lead Impedance</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Atrial Lead Noise</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Elevated Pacing Thresholds</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Lead Insulation Damage</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Loss of Capture</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Lead Fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RA Lead Related Undersensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Related Abnormal Lead Impedance</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Related Lead Insulation Damage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Related Elevated Pacing Thresholds</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Related Lead Externalization</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
              <event>
                <sub_title>RV Lead Related Oversensing</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="1930"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Clay Cohorn, Clinical Program Director</name_or_title>
      <organization>Abbott</organization>
      <phone>972-309-8087</phone>
      <email>clay.cohorn@abbott.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

